Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2023 | The risk of bleeding in patients with von Willebrand disease hospitalized due to AMI

Orly Leiva • 9 Dec 2023
ASH 2023
Non-Malignant Rare Diseases Von Willebrand Disease

Orly Leiva, MD, NYU Langone Health, New York City, NY, discusses the risk of post-hospitalization bleeding in patients with von Willebrand disease (VWD) who have experienced acute myocardial infarction (AMI). Retrospective analyses have determined that the risk of bleeding is increased during post-AMI hospitalization in these patients. However, many questions about the chronic management of AMI in VWD remain unanswered. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Orly Leiva

1:21
Cardio-oncology: an emerging field within cancer treatment
Orly Leiva • 9 Dec 2023
0:52
The increased risk of thromboembolism in cancer
Orly Leiva • 9 Dec 2023
1:21
Cardiovascular disease is associated with poorer outcomes in patients with MPNs
Orly Leiva • 9 Dec 2023
1:53
The risk of heart failure in MPNs and the rate of CV-related readmissions following heart failure
Orly Leiva • 9 Dec 2023

Related Videos

0:46
The urgency of diagnosing and treating patients with Castleman disease
Karthik Ramasamy • 28 Apr 2024
2:01
The MDT in the new era of gene therapy for hemoglobinopathies
Mattia Algeri • 15 Apr 2024
2:38
Treosulfan vs busulfan conditioning in pediatric patients with non-malignant diseases
Rita Beier • 15 Apr 2024
3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals